SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-181874
Filing Date
2015-05-11
Accepted
2015-05-11 16:02:18
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d907201d10q.htm 10-Q 500626
2 EX-31.1 d907201dex311.htm EX-31.1 5960
3 EX-31.2 d907201dex312.htm EX-31.2 6004
4 EX-32.1 d907201dex321.htm EX-32.1 3387
5 EX-32.2 d907201dex322.htm EX-32.2 3427
  Complete submission text file 0001193125-15-181874.txt   3116986

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20150331.xml EX-101.INS 354427
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20150331.xsd EX-101.SCH 29264
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20150331_cal.xml EX-101.CAL 47164
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20150331_def.xml EX-101.DEF 84440
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20150331_lab.xml EX-101.LAB 259910
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20150331_pre.xml EX-101.PRE 170891
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 15850603
SIC: 2834 Pharmaceutical Preparations